Having trouble accessing articles? Reset your cache.

Management tracks: Bourla to succeed Read as Pfizer chair; plus Phathom, OnKure, Forma, Beam, Noven, Cerebral, Alpha Tau and InsightRX

Ian Read will retire as chairman of Pfizer Inc. (NYSE:PFE) on Dec. 31, with CEO Albert Bourla his successor. Read has been with the pharma since 1978, becoming CEO in 2010 and chairman in 2011. Bourla replaced Read as CEO on Jan. 1. Prior to that, Bourla spent a year as COO and three years leading Pfizer’s most productive business division by new drug

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers